Malignant disease | |||||
---|---|---|---|---|---|
Malignant disease / Antibody responsive malignancy | |||||
atezolizumab [Specialist drug] | On Formulary |
NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA823 NICE TA638 NICE TA639 NICE TA666 |
|||
Solution for infusion | |||||
Tecentriq (Roche Products Ltd) | On Formulary | ||||
bevacizumab [Specialist drug] |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA946 |
||||
Solution for infusion | |||||
Avastin (Roche Products Ltd) | Restricted | ||||
brentuximab vedotin [Specialist drug] | On Formulary |
NICE TA478 NICE TA641 NICE TA524 NICE TA577 |
|||
cetuximab [Specialist drug] |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
||||
Solution for infusion | |||||
Erbitux (Merck Serono Ltd) | On Formulary | ||||
obinutuzumab [Specialist drug] |
NICE TA343 NICE TA513 NICE TA629 |
||||
Solution for infusion | |||||
Gazyvaro (Roche Products Ltd) | On Formulary | ||||
pertuzumab [Specialist drug] |
NICE TA424 NICE TA509 NICE TA569 |
||||
Solution for infusion | |||||
Perjeta (Roche Products Ltd) | On Formulary | ||||
rituximab |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
||||
Solution for infusion | |||||
Truxima (Celltrion Healthcare UK Ltd) | On Formulary | ||||
trastuzumab emtansine [Specialist drug] | On Formulary |
NICE TA458 NICE TA632 |
|||
Malignant disease / Immunotherapy responsive malignancy | |||||
Bacillus Calmette-Guérin [Specialist drug] | On Formulary | ||||
lenalidomide [Specialist drug] | On Formulary |
NICE TA322 NICE TA171 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
thalidomide [Specialist drug] | On Formulary |
NICE TA228 |
|||
Malignant disease / Targeted therapy responsive malignancy | |||||
bortezomib [Specialist drug] |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
||||
Powder for solution for injection | |||||
Velcade (Janssen-Cilag Ltd) | Restricted | ||||
palbociclib [Specialist drug] | On Formulary |
NICE TA495 NICE TA836 |
|||
Malignant disease / Cytotoxic responsive malignancy | |||||
carboplatin [Specialist drug] |
NICE TA284 NICE TA285 |
||||
Solution for infusion | |||||
Carboplatin (Non-proprietary) | On Formulary | ||||
cisplatin [Specialist drug] | |||||
Solution for infusion | |||||
Cisplatin (Non-proprietary) | On Formulary | ||||
cladribine |
NICE TA616 |
||||
Solution for injection | |||||
Litak (Lipomed GmbH) | On Formulary | ||||
Solution for infusion | |||||
Leustat (Atnahs Pharma UK Ltd) | On Formulary | ||||
cyclophosphamide | |||||
Powder for solution for injection | |||||
Cyclophosphamide (Non-proprietary) | On Formulary | ||||
cytarabine [Specialist drug] | |||||
Solution for injection | |||||
Cytarabine (Non-proprietary) | On Formulary | ||||
epirubicin hydrochloride [Specialist drug] | |||||
Solution for infusion | |||||
Pharmorubicin (Pfizer Ltd) | On Formulary | ||||
eribulin [Specialist drug] |
NICE TA423 NICE TA515 |
||||
Solution for injection | |||||
Halaven (Eisai Ltd) | On Formulary | ||||
etoposide [Specialist drug] | |||||
Solution for infusion | |||||
Etoposide (Non-proprietary) | On Formulary | ||||
fluorouracil | |||||
Solution for injection | |||||
Fluorouracil (Non-proprietary) | On Formulary | ||||
Solution for infusion | |||||
Fluorouracil (Non-proprietary) | On Formulary | ||||
ifosfamide [Specialist drug] | |||||
Powder for solution for injection | |||||
Ifosfamide (Non-proprietary) | On Formulary | ||||
methotrexate | |||||
Solution for injection | |||||
Methotrexate (Non-proprietary) | On Formulary | ||||
Metoject PEN (medac UK) | On Formulary | ||||
Solution for infusion | |||||
Methotrexate (Non-proprietary) | On Formulary | ||||
vinblastine sulfate [Specialist drug] | |||||
Solution for injection | |||||
Vinblastine sulfate (Non-proprietary) | On Formulary | ||||
vincristine sulfate [Specialist drug] | |||||
Solution for injection | |||||
Vincristine sulfate (Non-proprietary) | On Formulary | ||||
Malignant disease / Cytotoxic drug-induced side effects | |||||
folinic acid | On Formulary |
NICE TA212 |
|||
mesna | On Formulary | ||||
Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
allopurinol | On Formulary | ||||
Malignant disease / Hormone responsive malignancy | |||||
bicalutamide | On Formulary | ||||
cyproterone acetate | On Formulary | ||||
degarelix |
NICE TA404 |
||||
Powder and solvent for solution for injection | |||||
Firmagon (Ferring Pharmaceuticals Ltd) | Restricted | ||||
goserelin | On Formulary | ||||
lanreotide | Restricted | ||||
leuprorelin acetate | On Formulary | ||||
Powder and solvent for suspension for injection | |||||
Prostap SR DCS (Takeda UK Ltd) | On Formulary | ||||
octreotide | On Formulary | ||||
Solution for injection | |||||
Octreotide (Non-proprietary) | On Formulary | ||||
Sandostatin (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Powder and solvent for suspension for injection | |||||
Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
triptorelin | On Formulary | ||||
Powder and solvent for suspension for injection | |||||
Decapeptyl SR (Ipsen Ltd) | On Formulary | ||||
Gonapeptyl Depot (Ferring Pharmaceuticals Ltd) | On Formulary | ||||
Malignant disease / Hormone responsive breast cancer | |||||
anastrozole | On Formulary | ||||
exemestane | On Formulary | ||||
fulvestrant | On Formulary |
NICE TA503 |
|||
letrozole | On Formulary | ||||
tamoxifen | On Formulary | ||||
Oral solution | |||||
Tamoxifen (Non-proprietary) | On Formulary | ||||
Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
calcitonin (salmon) | On Formulary | ||||
Solution for injection | |||||
Calcitonin (salmon) (Non-proprietary) | On Formulary | ||||
denosumab | On Formulary |
NICE TA204 NICE TA265 |
|||
Solution for injection | |||||
Prolia (Amgen Ltd) | On Formulary | ||||
Xgeva (Amgen Ltd) | On Formulary | ||||
pamidronate disodium | On Formulary | ||||
Solution for infusion | |||||
Pamidronate disodium (Non-proprietary) | On Formulary | ||||
sodium clodronate | On Formulary | ||||
zoledronic acid | Restricted |
NICE TA464 |
|||
Infusion | |||||
Aclasta (Sandoz Ltd) | Restricted | ||||
Zometa (Phoenix Labs Ltd) | Restricted |